Cargando…
Considerations for the Use of Phage Therapy in Clinical Practice
Increasing antimicrobial resistance and medical device-related infections have led to a renewed interest in phage therapy as an alternative or adjunct to conventional antimicrobials. Expanded access and compassionate use cases have risen exponentially but have varied widely in approach, methodology,...
Autores principales: | Suh, Gina A., Lodise, Thomas P., Tamma, Pranita D., Knisely, Jane M., Alexander, Jose, Aslam, Saima, Barton, Karen D., Bizzell, Erica, Totten, Katherine M. C., Campbell, Joseph L., Chan, Benjamin K., Cunningham, Scott A., Goodman, Katherine E., Greenwood-Quaintance, Kerryl E., Harris, Anthony D., Hesse, Shayla, Maresso, Anthony, Nussenblatt, Veronique, Pride, David, Rybak, Michael J., Sund, Zoe, van Duin, David, Van Tyne, Daria, Patel, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923208/ https://www.ncbi.nlm.nih.gov/pubmed/35041506 http://dx.doi.org/10.1128/aac.02071-21 |
Ejemplares similares
-
Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial
por: Tamma, Pranita D., et al.
Publicado: (2022) -
693 Comparison of the 2011 Musculoskeletal Infection Society (MSIS), the 2013 International Consensus Meeting (ICM) and the Infectious Diseases Society of America (IDSA) Diagnostic Criteria for Prosthetic Joint Infection (PJI)
por: Melendez, Dante, et al.
Publicado: (2014) -
Selected Antimicrobial Activity of Topical Ophthalmic Anesthetics
por: Reynolds, Margaret M., et al.
Publicado: (2016) -
215. Shorter vs. Longer Duration of Treatment in Patients with Ceftriaxone-resistant and Ceftriaxone-susceptible Escherichia coli Bloodstream Infections
por: Mackow, Natalie A, et al.
Publicado: (2023) -
Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms
por: Simner, Patricia J, et al.
Publicado: (2018)